Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 70.90B P/E 10.66 EPS this Y 7.50% Ern Qtrly Grth -27.80%
Income 4.03B Forward P/E 8.79 EPS next Y 11.10% 50D Avg Chg -1.00%
Sales 31.45B PEG 2.05 EPS past 5Y 0.53% 200D Avg Chg -1.00%
Dividend 2.00% Price/Book 5.53 EPS next 5Y 4.80% 52W High Chg -15.00%
Recommedations 2.40 Quick Ratio 0.53 Shares Outstanding 2.04B 52W Low Chg 22.00%
Insider Own 0.06% ROA 9.56% Shares Float 3.95B Beta 0.31
Inst Own 15.48% ROE 33.30% Shares Shorted/Prior 11.69M/9.65M Price 34.63
Gross Margin 72.78% Profit Margin 12.83% Avg. Volume 3,079,743 Target Price 45.88
Oper. Margin 28.10% Earnings Date Oct 30 Volume 2,137,258 Change -0.86%
About GSK plc

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development, as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

GSK plc News
12/17/24 GSK announces CHMP of the EMA recommended expanding approval of Jemperli
12/17/24 GSK announces FDA granted BTD for Jemperli
12/17/24 GSK’s lung cancer therapy gains EMA PRIME designation
12/10/24 GSK's Blood Cancer Drug Shows Improved Survival Compared To Johnson & Johnson's Darzalex
12/09/24 Belantamab Mafodotin shows significant overall survival benefit, reducing the risk of death by 42% in multiple myeloma at or after first relapse
12/04/24 Investors shift to US funds and tech in November amid lower interest rates
12/03/24 GSK (LON:GSK) investors are sitting on a loss of 3.4% if they invested five years ago
10:29 AM GSK gains approval in Japan for extended indication of RSV vaccine
11/23/24 GSK announces Japan’s MHLW approved application to extend indication of Arexvy
11/19/24 GSK's Investigational Liver Disease Candidate Hits Primary Goal In Late-Stage Study To Treat Relentless Itch In Some Patients
11/18/24 Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer
11/15/24 How analysts are reacting to RFK Jr. as Trump's HHS pick
11/15/24 Stocks to Watch Friday: Applied Materials, Alibaba, Domino's, Novo Nordisk
11/15/24 Trump’s RFK Jr. Pick Weighs on Vaccine Makers
11/15/24 Trump looks to end EV credit, vaccine stocks fall on RFK JR. pick
11/15/24 Analysts think Wall Street's reaction to the RFK Jr. news is 'overdone.' Sort of.
11/15/24 European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department
11/14/24 Moderna, Novavax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official
11/14/24 GSK Raises Prospects For Withdrawn Blood Cancer Drug Blenrep To Return To US Market - Here's Why
11/13/24 Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease